- VernacularTitle:我国西北地区36万成人心血管病高危风险的特征
- Author:
Wei XU
1
,
2
,
3
,
4
,
5
;
Xingyi ZHANG
1
,
2
,
3
,
4
,
5
;
Jiapeng LU
1
,
2
,
3
,
4
,
5
;
Xinghe HUANG
1
,
2
,
3
,
4
,
5
;
Bo GU
1
,
2
,
3
,
4
,
5
;
Lijuan SONG
1
,
2
,
3
,
4
,
5
;
Jianlan CUI
1
,
2
,
3
,
4
,
5
;
Yan LI
1
,
2
,
3
,
4
,
5
;
Haibo ZHANG
1
,
2
,
3
,
4
,
5
;
Xi LI
1
,
2
,
3
,
4
,
5
;
Jiamin LIU
1
,
2
,
3
,
4
,
5
Author Information
- Publication Type:Journal Article
- Keywords: cardiovascular disease; high-risk population; risk factor; medication
- From: Journal of Xi'an Jiaotong University(Medical Sciences) 2021;42(5):784-790
- CountryChina
- Language:Chinese
- Abstract: 【Objective】 To assess the prevalence and treatment of high cardiovascular disease (CVD) risk, and identify individual characteristics related to high CVD risk. 【Methods】 Based on the data of the China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE) Million Persons Project (MPP) from 2016 to 2019, this study enrolled local residents aged 35 to 75 years from 39 counties or districts in Northwest China. Rates of high CVD risk and individual characteristics were assessed in the overall study population. Statin and aspirin use was also evaluated among those at high risk for CVD. Multivariable mixed models were fitted to evaluate the relationship between individual characteristics and high CVD risk. 【Results】 Among 364 537 participants, the average age was (54.6±9.7)years, and 5.8% was at a high risk for CVD. Multivariate mixed models showed that individuals who were currently using alcohol, overweight or obese tended to have a high risk for CVD, while married persons, those with a higher education level or a higher household income were correlated with a lower risk for CVD (all P<0.05). Among high-risk persons, hypertension was the most prevalent risk factor (98.1%), and only 1.3% and 3.5% reported their use of statins and aspirin, respectively. 【Conclusion】 Of the 364 537 participants, about 1 in 17 had a high risk for CVD. Among those at a high CVD risk, only less than 4% reported taking statins or aspirin. These findings indicate that there is still much room for risk mitigation in this population in China.